MTOR and cervical carcinoma: However, at the same time, another study of the CDKN2Aexpression in cervical cancer cell lines showed that it wasreduced; moreover, the authors concluded that CDKN2A inhibitscell proliferation and invasion in cervical cancer throughthe lactate dehydrogenase-mediated ACT-mTOR pathway(Luan et al., 2021).